Cargando…
Myeloid Differentiation Primary Response 88–Cyclin D1 Signaling in Breast Cancer Cells Regulates Toll-Like Receptor 3-Mediated Cell Proliferation
Toll-like receptor 3 (TLR3)-mediated apoptotic changes in cancer cells are well-documented, and hence, several synthetic ligands of TLR3 are being used for adjuvant therapy, but there are reports showing a contradictory effect of TLR3 signaling, which include our previous report that had shown cell...
Autores principales: | Singh, Aradhana, Devkar, Ranjitsinh, Basu, Anupam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531238/ https://www.ncbi.nlm.nih.gov/pubmed/33072559 http://dx.doi.org/10.3389/fonc.2020.01780 |
Ejemplares similares
-
Prognostic Value of Myeloid Differentiation Primary Response 88 and Toll-Like Receptor 4 in Breast Cancer Patients
por: Ma, Fang-Jing, et al.
Publicado: (2014) -
HSP60 knockdown exerts differential response in endothelial cells and monocyte derived macrophages during atherogenic transformation
por: Shirsath, Kavita, et al.
Publicado: (2021) -
Protein overexpression of toll-like receptor 4 and myeloid differentiation factor 88 in oral squamous cell carcinoma and clinical significance
por: Li, Lili, et al.
Publicado: (2021) -
Toll-like receptor 4 and myeloid differentiation factor 88 are required for gastric bypass-induced metabolic effects
por: Haija, Marwa Abu El, et al.
Publicado: (2021) -
High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer
por: Wang, E L, et al.
Publicado: (2010)